Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 167

Results For "science"

1727 News Found

AIkido updates on use of machine learning in drug development orogram
Digitisation | August 09, 2021

AIkido updates on use of machine learning in drug development orogram

The goal for the project is the identification and optimization of anti-viral compounds.


Carbon-based non-toxic and reusable wrapper to increase shelf life of fruits
Sustainability | August 09, 2021

Carbon-based non-toxic and reusable wrapper to increase shelf life of fruits

This work has been published in the journal ‘ACS applied materials and interface’


India's doctor-population ratio to reach WHO benchmark soon: Dr Vinod Paul
Healthcare | August 09, 2021

India's doctor-population ratio to reach WHO benchmark soon: Dr Vinod Paul

By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas


Strides Pharma reports Q1FY22 consolidated loss at Rs 205.2 Cr
Biotech | August 08, 2021

Strides Pharma reports Q1FY22 consolidated loss at Rs 205.2 Cr

The company expects revenue growth of 10-15 per cent in the US


Stelis Biopharma appoints Mark W. Womack as CEO
People | August 07, 2021

Stelis Biopharma appoints Mark W. Womack as CEO

He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations


India’s gets its first bio-bank for heart failure research
Drug Approval | August 06, 2021

India’s gets its first bio-bank for heart failure research

Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology


Strides to acquire US manufacturing facility of Endo for $24 mn
News | August 06, 2021

Strides to acquire US manufacturing facility of Endo for $24 mn

The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.


Mark W. Womack is the new CEO of Stelis Biopharma
Biotech | August 06, 2021

Mark W. Womack is the new CEO of Stelis Biopharma

He will be stationed at the company HQ in Bengaluru, India


Govt augments PSEs and Bharat Biotech to ramp up Covaxin production
Policy | August 06, 2021

Govt augments PSEs and Bharat Biotech to ramp up Covaxin production

CDSCO to fast-track trials and approval for COVID19 vaccine


Scientists from BRICS work on genomic sequencing of Covid-19
Drug Approval | August 06, 2021

Scientists from BRICS work on genomic sequencing of Covid-19

Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread